3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
6
Colorectal Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Pain
2
Lung Neoplasms
2
Hematopoietic and Lymphatic System Neoplasm
2
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sedentary Behavior
1
Sarcoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Polyps
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Motor Activity
1
Metastatic Pancreatic Adenocarcinoma
1
Malignant Hepatobiliary Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Insulin Resistance
1
Hodgkin Disease
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Interventions
Radiotherapy
2
Radiosurgery
2
Urine Specimen Collection
1
Trastuzumab
1
Therapeutic Irrigation
1
Telemedicine
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Radiofrequency Ablation
1
Prostatectomy
1
Oxaliplatin
1
Negative-Pressure Wound Therapy
1
Narrow Band Imaging
1
Microscopy, Confocal
1
Longitudinal Studies
1
Liquid Biopsy
1
Leuprolide
1
Esophagectomy
1
Endoscopy
1
Docetaxel
1
Diagnostic Imaging
1
Dashboard Systems
1
Capecitabine
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Adenocarcinoma
×
Telemedicine
×
Clear all
NCT04667403
2022-04-28
PANTELO
Institut Cancerologie de l'Ouest
Phase NA
Unknown
50 enrolled